- TV Footage
- Financial Reports
- Newsletter Overview
- Social Media
- Media Contact
Monheim, September 30, 2019 – Bayer has appointed Ingo Elfering as the new Chief Information Officer (CIO) and Head of Digital Transformation of Crop Science, a division of Bayer, effective October 1, 2019. He succeeds Jim Swanson who is leaving the company on the 30th of September. Elfering will report to Daniel Hartert, Bayer Group CIO and join the company’s global IT Leadership Team and the Crop Science Executive Leadership Team. Elfering will be based in Saint Louis, Missouri, USA and lead the digital transformation in Crop Science while continuing to lead Business Services in the U.S.
“Ingo Elfering brings strong corporate and entrepreneurial experience as a leader who has successfully driven large-scale strategic and innovative change programs,” said Liam Condon, member of the Board of Management of Bayer AG and President of the Crop Science Division. “His previous success in driving change in complex global environments will benefit all of us at Bayer as digital transformation is a core enabler of our business strategy and growth.”
“I am really excited about the digital transformation of agriculture and look forward to helping drive this forward with Bayer as the leading company in this space,” said Elfering. “I look forward to working with teams across the globe to develop and implement solutions to create new value for customers and our business.”
Prior to joining Bayer in 2018, Elfering served as CIO and Innovation Officer at Indivior (formerly Reckitt Benckiser Pharmaceuticals) in Richmond, Virginia. Previously, he gained broad leadership experience with GlaxoSmithKline, where he was responsible for disruptive innovation, core business services, business transformation and various global roles in IT. Prior to that, he successfully founded, ran and sold a start-up company in Germany.
Elfering studied Business Informatics at the University of Munster and the School of Applied Sciences & Arts Dortmund as well as participated in further education with the Wharton School in the U.S.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.